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Summary: Twenty five different analytical procedures, commonly used in clinical laboratories, were in-
vestigated for interference by eight analgesic and antirheumatic drugs. Ten of the investigated assays showed
no statistically significant interference.
Acetylsalicylic acid interfered in six assays (for glucose, uric acid, protein* and cholesterol). Aminophenazone
significantly decreased glucose, bilirubin and protein values, whereas caffeine affected four methods (for
glucose, protein and iron).
No definite influence of phenobarbital could be detected on any assay. Glucose, uric acid and iron values
were altered in the presence of diclofenac. Indomethacin interfered in glucose, urea, uric acid and protein
assays.
Samples containing ibuprofen had altered creatinine, bilirubin and iron values, whereas ketoprofen interfered
in glucose and iron determination.
Untersuchung von 25 üblichen Laboratoriumsmethoden hinsichtlich ihrer Störanfälligkeit durch Analgetica und
Antirheumatica.
Zusammenfassung: Fünfundzwanzig verschiedene analytische, in klinischen Laboratorien übliche Verfahren
wurden hinsichtlich ihrer Störanfälligkeit durch acht Analgetica und Antirheumatica untersucht. Zehn dieser
Methoden zeigten keine statistisch signifikante Störung.
Acetylsalicylsäure störte bei sechs Verfahren zur Bestimmung von Glucose, Harnsäure, Protein und Choleste-
rin. Aminophenazon verminderte Glucose-, Bilirubin- und Proteinwerte signifikant, während Coffein vier
Methoden zur Bestimmung von Glucose, Protein und Eisen störte.
Phenobarbital war ohne jeglichen Einfluß auf die untersuchten Methoden. Glucose-, Harnsäure- und Eisen-
werte waren in Gegenwart von Diclofenac verändert. Indomethacin störte Glucose-, Harnstoff-, Harnsäure-
und Pröteinbestimmungen. Ibuprofen enthaltende Proben ergaben veränderte Kreatinin-, Bilirubin- und
Eisenwerte, während Ketoprofen bei Glucose- und Eisenbestimmungen störte.
Introduction
in the treatment of various rheumatic diseases.
In our previous investigation, effects of analgesic and Analgetic preparations containing acetylsalicylic acid,
antirheumatic drugs on the assay of serum enzymes aminophenazone, phenobarbital or cafieine are also
(1) and SMA H procedures (2) were examined. frequently used in self-medication. It is thus import-
Acetylsalicylic acid, aminophenazone, indoinethacin, ant to know whether these drugs alter clinical lab-
diclofenac, ibuprofen and ketoprofen are widely used oratory test results.
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In the present work, we investigated the effects of
these eight drugs (in vitro) on 25 of the most fre-
quently used methods for the determination of
glucose, urea, uric acid, creatinine, bilirubin, protein,
cholesterol, triglycerides and iron.


























To examine the drug interferences in common laboratory
assays, the general protocol by Slest et al. (3) was followed.
Commercial lyophilized human sera were reconstituted with
Solutions of each drug tested. The drug concentfations (tab. 1)
were approximately ten times the maximal therapeutic levels
(4-7).
Aqueous Solutions of acetylsalicylic 'acid, aminophenazone,
caffeine, phenobarbital, diclofenac and indomethacin were
made. For control sample preparation, the drug Solutions were
replaced by distilled water. To dissolve ibuprofen and keto-
profen, ethanol was added in a final coiicentration of 200 g/l,
and additional control samples were prepared, containing the
same concentration of ethanol.
Glucose, urea, uric acid, creatinine, bilirubin, protein, chol-
esterol, triglyceride and iron concentrations were determined
by varipus methods commonly used in clinical laboratories.
The principles and reference data of the methods are shown in
table 2.
For each method, six replicate tests were performed on control
samples and samples containing the drug; the statistical para-
meters: mean value (x) and Standard deviatipn (s) were deter-
mined. Using Studenfs t-test, the significance of the differences
between values obtained in sera with and without drugs was
assessed. All tests for a specific group of samples (sera con-
taining the drug and cprresponding controls) were completed
in a single run.
The interferences öbserved were studied further using lower
drug concentrations down to the therapeutic levels. Con-
centrations of drugs in samples were gradually decreased and
drug effects tested, until statistically unsignificant differences
were found.
The assays were performed with a Pye Unicam spectro-
photometer SP 8-100.











Hexokinase and glucose-6-phosphate dehydrogenase
Glucose dehydrogenase
Glucose oxidase and peroxidase, using 4-aminophenazone and
2,4-dichlorphenol äs chromogen
Glucose oxidase and peroxidase, using ABTS äs chromogen
ö-Toluidine




Uricase, catalase and aldehyde dehydrogenase
Direct UV-test with uricase
Continuous, with alkaline picräte




Direct spectrophotometric method (at 461 and 551 nm)
Biuret reaction
Direct spectrophotometric method (at 280 nm)
Enzymatic, with cholesterol esterase and cholesterol oxidase
Liebermann-Burchard reaction
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Results and Discussion
The effects of analgesic and antirheumatic drugs on
25 common laboratory assays are shown in
tables 3 — 5. The concentrations of analytes and their
variations obtained using different methods in
samples with and without the drugs are given, s well
s the corresponding p values. Ten assays showed no
statistically significant interference, i.e. the de-
termination of glucose (hexokinase method), urea
(with glutamate dehydrogenase and phenol-hypo-
chlorite method), uric acid (direct UV lest and
phosphotungstate inethod), creatinine (continuous
and Slofs method), bilirubin (Jendrassik-GroJ), chol-
esterol and triglycerides (enzymatic assays). No defi-
nite influence of phenobarbital could be detected on
any method (tab. 4).
Acetylsalicylic acid interfered in six assays (for
glucose, uric acid, protein and cholesterol de-
termination) (tab. 3). Out of five glucose assays
tested, two were affected by the drug: the glucose
dehydrogenase method and the glucose oxidase-
peroxidase procedure using ABTS s chromogen.
Acetylsalicylic acid has been reported to have no in
vitro effect on the alkaline ferricyanide, p-HBAH and
o-toluidine methods (33). In sera containing the drug,
apparent concentrations of uric acid (with uricase
and catalase) and protein (direct spectrophotometric
assay) were very significantly increased (p < 0.01 and
p < 0.005, respectively). Wirth & Thompson (34) re-
ported interference by acetylsalicylic acid in the Polin-
Ciocalteu protein assay in body fluids. Lower cho-
lesterol values were obtained using the Liebermann-
Burchard method (p < 0.01), which is in agreement
with findings reported by Caraway & Kammeyer (35).
Aminophenazone significantly decreased the results
for glucose (with ABTS, p < 0.001), bilirubin (with
dimethylsulphoxide, p < 0.05), and protein (biuret
method, p < 0.05). The drug is also known to increase
the results of the cholesterol determination based on
reaction with ferric ions in acetic acid-sulphuric acid
(33, 35).
Tab. 3.Effects of acetylsalicylic acid, aminophenazone and caffeine on some common laboratory tests (N
degrees of freedom 0 = 2N-2 = 10).




Acetylsalicylic aeid Aminophenazone Caffeine
x s p x s p x s p
Glucose (mmol/1)
hexokinase 4.75 0.156 4.68 0.148 >0.4 4.62 0.150 >0.2 4.71 0.069 >0.5
glucose dehydrogenase 4.24 0.099 4.32 0.339 >0.6 4.33 0.190 >0.3 4.08 0.064 <0.02
2,4-dichlorphenol 3.69 0.245 4.10 0.155 <0.02 3.56 0.230 >0.4 3.74 0.316 >0.8
ABTS 3.93 0.078 4.03 0.037 <0.05 3.61 0.033 <0.001 4.06 0.019 <0.005
o-toluidine 5.09 0.061 5.16 0.066 >0.01 5.05 0.115 >0.4 4.95 0.173 >0.1
Urea (mmol/1)
glutamate dehydrogenase 6.00 0.241 5.79 0.273 >0.2 6.13 0.519 >0.6 6.24 0.070 >0.05
phenol-hypochlorite 6.66 0.543 6.18 0.188 >0.05 6.59 0.467 >0.8 6.57 0.386 >0.7
diacetylmonoxime 6.60 0.155 6.83 0.560 >0.4 6.42 0.428 >0.3 6.33 0.426 >0.2
Uric acid (μιηοΐ/ΐ)
uricase-catalase 167 5.34 177 4.45 <0.01 161 9.57 >0.25 177 11.71 >0.05
aldehyde dehydrogenase 170 2.58 170 11.92 >0.9 176 13.62 >0.3 165 5.06 >0.05
direct UV-test 178 16.18 171 13.61 >0.4 181 10.53 >0.7 163 9.28 >0.05
phosphotungstate 214 10.41 218 4.59 >0.4 209 15.81 >0.5 207 14.64 >0.4
Creatinine (μπιοΐ/ΐ)
continuous 90.8 1.94 89.6 1.09 >0.25 89.8 0.49 >0.25 91.3 2.16 >0.7
with deproteinization 85.6 1.602 83.3 2.077 >0.05 84.4 1.788 >0.25 84.8 1.174 >0.3
Slot 95.7 9.16 98.2 8.57 >0.6 98.9 2.94 >0.4 95.9 7.90 >0.9
Bilirubin (μπιοΐ/ΐ)
Jendrassik-Grof 29.2 1.699 28.9 0.389 >0.6 27.6 0.349 >0.05 28.7 0.802 >0.5
dunethylsulphoxide 20.1 1.542 · 20.6 0.446 >0.5 16.4 1.196 <0.005 19.4 1.394 >0.4
spectrophotpmetric 20.2 1.470 19.8 1.664 >0.6 19.0 1.829 >0.25 19.6 1.420 >0.5
Protein (g/l)
biuret 59.5 0.969 55.6 3.313 <0.025 57.7 1.605 <0.05 59.1 1.482 >0.5
spectrophotometric 51.1 1.282 55.8 1.970 < 0.005 51.5 1.482 >0.6 56.7 1.908 < 0.001
Cholesterol (mmol/l)
enzymatic 2.63 0.140 2.59 0.130 >0.6 2.71 0.175 >0.4 2.66 0.145 >0.7




bathophenanthroline 16.9 0.956 16.0 0.821 >0.1 16.2 0.554 >0.25 16.4 0.629 >0.3
Ramsay 20.4 1.607 19.5 0.687 >0.2 18.9 0.673 >0.05 18.4 1.001 <0.05
Ό.79 0.045 >0.8 0.80 0.043 >0.4 0.80 0.041 >0.5
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Caffeine affected four tests (tab. 3). Glucose values
were very significantly increased (ABTS method,
p < 0.005), s well s protein (spectrophotometric
assay, p < 0.001). Interference by caffeine in the uric
acid assay using phosphotungstate has been reported
(35), but the effect was found to be significant only
in the determination of uric acid in urine.
Effects of diclofenac and indpmethacin are shown in
table 4. In samples containing these drugs, the values
for glucose (with ABTS) and uric acid values (with
uricase and catalase and with aldehyde dehydro-
genase) were elevated. Indomethacin affected very
significantly the results of the glucose determination
(with glucose dehydrogenase, p < 0.005), and the
protein determination (biuret method, p < 0.005).
Creatinine (with deproteinization) and iron (Ramsay)
values were increased in sera containing ibuprofen
(tab. 5). Ketoprofen interfered in glucose (with
ABTS, p < 0.02) and iron assays (with batho-
phenanthroline, p < 0.05 and Ramsay method,
p < 0.005). No data have been previously reported
on analytical interferences by diclofeiiac, indo-
methacin and ketoprofen.
' r
The effects found were studied further using lower
concentrations of drugs, down to the therapeutic
levels. Interference by aminophenazone in tbe glucose
determination (with ABTS) was still evident at
216 μιηοΐ of drug per liter (p < 0.025). Lower con-
centration of diclofenac (28 μπιοΐ/ΐ) significantly in^
creased the results of the same test (p < 0.05).
Figurel shows the d se dependence of these two
interferences. In lower concentrations, other drugs
did not interfere with any assay, so the effects found
are significant only in cases of drug overdosage or
poisoning.
Tab. 4. Phenobarbital, diclofenac and indomethacin interference in common laboratory assays (N = 6, n mber of the degrees of
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1QQ 200 300 400» 500
Aminophenazone [μιηοΐ/ΐ]
200 400 600 800
Diclofenac [jimol/l]
1000
Fig. 1. Dose dependence of aminophenazpne (a) and diclofenac (b) interference in the glucose assay with glucose oxidase and
peroxidase using ABTS s chromogen.
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